MoonLake Immunotherapeutics

Q3 2022 13F Holders

Symbol: MLTX
CUSIP: 61559X104
Type: Equity
Class: CLASS A ORD
Num filings: 25
Total reported value, excl. options: $291 M

Compare 2022 Q3 to

Manager	Report Date	Value ($000)	Shares	Option Type